$CDNA

INSTITUTIONAL QUANT REPORT

Constitution Metrics (S-GRADE)

ROE

29.5%

S&P 500 Alpha: 2.0x

ROIC

-0.4%

Cash Holdings

$0.0

AI 전문 투자 리포트

🔥 [AI Catalyst] The 100x return secret created by focusing on ROIC CDNA presents an intriguing investment opportunity with a robust ROE of 29.49%, signaling strong profitability. Despite its current market cap of $2.4 billion and a favorable P/E ratio of 22.75, potential investors should carefully weigh growth prospects against financial stability indicators. With $373.6 million in net cash, there’s room for strategic investments that could drive future growth.

Bull Case (상승 모멘텀)

1. High ROE: With a remarkable return on equity of 29.49%, CDNA is generating significant profits relative to shareholder equity, indicating effective management and potential for strong returns on investments. 2. Strong Cash Position: The company boasts $373.6 million in net cash, providing a solid financial cushion and flexibility to fund growth initiatives or navigate market volatility. 3. Attractive Valuation: The PEG ratio of 0.00 suggests that the stock may be undervalued relative to its growth potential, offering an enticing entry point for investors seeking long-term gains.

Bear Case (주의/리스크 요인)

1. Negative ROIC: The negative return on invested capital (-0.38%) raises concerns about the company's ability to generate value from its investments, which could limit growth prospects. 2. Stagnant Growth: With a 5Y CAGR of 0.00% and no revenue growth reported, it appears that CDNA may struggle to expand its market presence, making future profitability uncertain. 3. Value Trap Risk: Despite high ROE, the negative ROIC coupled with a lack of growth could signal a 'Value Trap,' where the stock appears attractive but fails to deliver on expected returns, leading to potential losses for investors.

마지막 분석: 8/23/2026